Literature DB >> 36051963

Commentary to Aby et al: serum ammonia use - unnecessary, frequent and costly.

Johannes Häberle1, James Nurse2,3, Fanny Mochel4.   

Abstract

Entities:  

Keywords:  acute liver failure; chronic liver disease; health economics; inherited metabolic disease

Year:  2022        PMID： 36051963      PMCID： PMC9380762          DOI： 10.1136/flgastro-2022-102132

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN： 2041-4137


× No keyword cloud information.
  5 in total

Review 1.  Clinical and biochemical aspects of primary and secondary hyperammonemic disorders.

Authors:  Johannes Häberle
Journal:  Arch Biochem Biophys       Date:  2013-04-27       Impact factor: 4.013

Review 2.  Clinical practice: the management of hyperammonemia.

Authors:  Johannes Häberle
Journal:  Eur J Pediatr       Date:  2010-12-17       Impact factor: 3.183

Review 3.  Peak hyperammonemia and atypical acute liver failure: The eruption of an urea cycle disorder during hyperemesis gravidarum.

Authors:  Nicolas Weiss; Fanny Mochel; Marika Rudler; Sophie Demeret; Pascal Lebray; Filomena Conti; Damien Galanaud; Chris Ottolenghi; Jean-Paul Bonnefont; Marc Dommergues; Jacques Bernuau; Dominique Thabut
Journal:  J Hepatol       Date:  2017-09-20       Impact factor: 25.083

4.  Serum ammonia use: unnecessary, frequent and costly.

Authors:  Elizabeth Aby; Andrew P J Olson; Nicholas Lim
Journal:  Frontline Gastroenterol       Date:  2021-08-18

5.  Adult-onset diagnosis of urea cycle disorders: Results of a French cohort of 71 patients.

Authors:  Ségolène Toquet; Marta Spodenkiewicz; Claire Douillard; François Maillot; Jean-Baptiste Arnoux; Lena Damaj; Sylvie Odent; Caroline Moreau; Isabelle Redonnet-Vernhet; Samir Mesli; Aude Servais; Esther Noel; Sybill Charriere; Vincent Rigalleau; Christian Lavigne; Elsa Kaphan; Agathe Roubertie; Gérard Besson; Adrien Bigot; Amélie Servettaz; Fanny Mochel; Roselyne Garnotel
Journal:  J Inherit Metab Dis       Date:  2021-06-07       Impact factor: 4.982
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.